Clinical Trial

Elevated Rate Pacing of Cardiac Amyloidosis

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to better quantify the improvements in heart failure symptoms and exercise tolerance before and after the heart rate elevation in a cohort of 10 cardiac amyloidosis patients with preexisting pacemakers.
Trial Details
NCT Number NCT07583823
Lead Sponsor University of Minnesota
Conditions Cardiac Amyloidosis, Pacemaker
Enrollment 10 participants
Start Date 2025-10-10
Primary Completion 2026-10-10 (estimated)
Study Completion 2026-10-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-13